USPTO Assignments on the Web

	United States Patent and Trademark Office
	Home\|Site Index\|Search\|Guides\|Contacts\|eBusiness\|eBiz alerts\|News\|Help

Assignments on the Web > Patent Query

Patent Assignment Details

NOTE:Results display only for issued patents and published applications. For pending or abandoned applications please consult USPTO staff.

Reel/Frame:	067410/0105			Pages:	19
		Recorded:	05/14/2024
Attorney Dkt #:	2370417KS
Conveyance:	SECURITY INTEREST (SEE DOCUMENT FOR DETAILS).

Total properties: 37

Patent #:	9932597	Issue Dt:	04/03/2018	Application #:	14523218	Filing Dt:	10/24/2014
Publication #:	US20150118714	Pub Dt:	04/30/2015
Title:	VECTORS FOR TRANSGENE EXPRESSION

Patent #:	10344074	Issue Dt:	07/09/2019	Application #:	15006224	Filing Dt:	01/26/2016
Publication #:	US20160137715	Pub Dt:	05/19/2016
Title:	T CELL RECEPTORS

Patent #:	10442849	Issue Dt:	10/15/2019	Application #:	15419398	Filing Dt:	01/30/2017
Publication #:	US20170166622	Pub Dt:	06/15/2017
Title:	COMPOSITIONS AND METHODS FOR TCR REPROGRAMMING USING FUSION PROTEINS

Patent #:	9976121	Issue Dt:	05/22/2018	Application #:	15713464	Filing Dt:	09/22/2017
Publication #:	US20180010095	Pub Dt:	01/11/2018
Title:	T Cells with Increased Immunosuppression Resistance

Patent #:	10689620	Issue Dt:	06/23/2020	Application #:	15949018	Filing Dt:	04/09/2018
Publication #:	US20180298338	Pub Dt:	10/18/2018
Title:	T Cells With Increased Immunosuppression Resistance

Patent #:	10358473	Issue Dt:	07/23/2019	Application #:	15965738	Filing Dt:	04/27/2018
Publication #:	US20180244747	Pub Dt:	08/30/2018
Title:	COMPOSITIONS AND METHODS FOR TCR REPROGRAMMING USING FUSION PROTEINS

Patent #:	10358474	Issue Dt:	07/23/2019	Application #:	15965739	Filing Dt:	04/27/2018
Publication #:	US20180251514	Pub Dt:	09/06/2018
Title:	COMPOSITIONS AND METHODS FOR TCR REPROGRAMMING USING FUSION PROTEINS

Patent #:	11111301	Issue Dt:	09/07/2021	Application #:	15998475	Filing Dt:	08/15/2018
Publication #:	US20190100592	Pub Dt:	04/04/2019
Title:	T Cell Modification and Use Thereof

Patent #:	11084862	Issue Dt:	08/10/2021	Application #:	16416907	Filing Dt:	05/20/2019
Publication #:	US20190330301	Pub Dt:	10/31/2019
Title:	T CELL RECEPTORS

Patent #:	11028142	Issue Dt:	06/08/2021	Application #:	16989602	Filing Dt:	08/10/2020
Publication #:	US20200362011	Pub Dt:	11/19/2020
Title:	COMPOSITIONS AND METHODS FOR TCR REPROGRAMMING USING FUSION PROTEINS

Patent #:	NONE	Issue Dt:		Application #:	17272865	Filing Dt:	03/02/2021
Publication #:	US20210317184	Pub Dt:	10/14/2021
Title:	T CELL MODIFICATION

Patent #:	NONE	Issue Dt:		Application #:	17297380	Filing Dt:	05/26/2021
Publication #:	US20240050570	Pub Dt:	02/15/2024
Title:	T Cell Modification

Patent #:	NONE	Issue Dt:		Application #:	17361524	Filing Dt:	06/29/2021
Publication #:	US20210324036	Pub Dt:	10/21/2021
Title:	T CELL RECEPTORS

Patent #:	NONE	Issue Dt:		Application #:	17468225	Filing Dt:	09/07/2021
Publication #:	US20220064305	Pub Dt:	03/03/2022
Title:	T Cell Modification and Use Thereof

Patent #:	11725040	Issue Dt:	08/15/2023	Application #:	17501122	Filing Dt:	10/14/2021
Publication #:	US20220031753	Pub Dt:	02/03/2022
Title:	T CELL RECEPTORS

Patent #:	11753456	Issue Dt:	09/12/2023	Application #:	17501200	Filing Dt:	10/14/2021
Publication #:	US20220025013	Pub Dt:	01/27/2022
Title:	T CELL RECEPTORS

Patent #:	12060404	Issue Dt:	08/13/2024	Application #:	17574152	Filing Dt:	01/12/2022
Publication #:	US20220127327	Pub Dt:	04/28/2022
Title:	T CELL RECEPTORS

Patent #:	NONE	Issue Dt:		Application #:	17630880	Filing Dt:	01/27/2022
Publication #:	US20220275335	Pub Dt:	09/01/2022
Title:	CULTURE MEDIUM FOR HAEMATOPOIETIC INDUCTION

Patent #:	NONE	Issue Dt:		Application #:	17630882	Filing Dt:	01/27/2022
Publication #:	US20220267733	Pub Dt:	08/25/2022
Title:	METHODS OF PRODUCING HAEMOGENIC PROGENITOR CELLS FROM PLURIPOTENT STEM CELLS

Patent #:	NONE	Issue Dt:		Application #:	17630884	Filing Dt:	01/27/2022
Publication #:	US20220267729	Pub Dt:	08/25/2022
Title:	METHODS OF T CELL PRODUCTION

Patent #:	NONE	Issue Dt:		Application #:	17630885	Filing Dt:	01/27/2022
Publication #:	US20220275395	Pub Dt:	09/01/2022
Title:	LENTIVIRAL TRANSDUCTION METHODS

Patent #:	NONE	Issue Dt:		Application #:	17812304	Filing Dt:	07/13/2022
Publication #:	US20220370559	Pub Dt:	11/24/2022
Title:	METHOD OF TREATMENT OF CANCER OR TUMOUR

Patent #:	NONE	Issue Dt:		Application #:	17819480	Filing Dt:	08/12/2022
Publication #:	US20230390334	Pub Dt:	12/07/2023
Title:	METHOD OF TREATMENT OF CANCER OR TUMOUR

Patent #:	11572400	Issue Dt:	02/07/2023	Application #:	17820529	Filing Dt:	08/17/2022
Publication #:	US20230028573	Pub Dt:	01/26/2023
Title:	T CELL RECEPTORS

Patent #:	NONE	Issue Dt:		Application #:	17923008	Filing Dt:	11/03/2022
Publication #:	US20240252641	Pub Dt:	08/01/2024
Title:	COMPOSITIONS AND METHODS FOR TCR REPROGRAMMING USING CD70 SPECIFIC FUSION PROTEINS

Patent #:	NONE	Issue Dt:		Application #:	17923008	Filing Dt:	11/03/2022
Publication #:	US20240252641	Pub Dt:	08/01/2024			PCT #:	US2130973
Title:	COMPOSITIONS AND METHODS FOR TCR REPROGRAMMING USING CD70 SPECIFIC FUSION PROTEINS

Patent #:	NONE	Issue Dt:		Application #:	17924926	Filing Dt:	03/17/2023
Publication #:	US20240016853	Pub Dt:	01/18/2024
Title:	MODIFIED IPSCS

Patent #:	NONE	Issue Dt:		Application #:	17924980	Filing Dt:	01/23/2023
Publication #:	US20230190802	Pub Dt:	06/22/2023
Title:	METHOD OF TREATMENT OF CANCER OR TUMOUR

Patent #:	NONE	Issue Dt:		Application #:	17924982	Filing Dt:	01/23/2023
Publication #:	US20230190803	Pub Dt:	06/22/2023
Title:	METHOD OF TREATMENT OF CANCER OR TUMOUR

Patent #:	NONE	Issue Dt:		Application #:	18046874	Filing Dt:	10/14/2022
Publication #:	US20230133064	Pub Dt:	05/04/2023
Title:	T CELL MANUFACTURING PROCESS

Patent #:	11965012	Issue Dt:	04/23/2024	Application #:	18069749	Filing Dt:	12/21/2022
Publication #:	US20230235010	Pub Dt:	07/27/2023
Title:	COMPOSITIONS AND METHODS FOR TCR REPROGRAMMING USING FUSION PROTEINS

Patent #:	NONE	Issue Dt:		Application #:	18269214	Filing Dt:	06/22/2023
Publication #:	US20240117002	Pub Dt:	04/11/2024
Title:	COMPOSITIONS AND METHODS FOR TCR REPROGRAMMING USING FUSION PROTEINS

Patent #:	NONE	Issue Dt:		Application #:	18269214	Filing Dt:	06/22/2023
Publication #:	US20240117002	Pub Dt:	04/11/2024			PCT #:	US2165069
Title:	COMPOSITIONS AND METHODS FOR TCR REPROGRAMMING USING FUSION PROTEINS

Patent #:	NONE	Issue Dt:		Application #:	18339663	Filing Dt:	06/22/2023
Publication #:	US20240218043	Pub Dt:	07/04/2024
Title:	T CELL RECEPTORS

Patent #:	NONE	Issue Dt:		Application #:	18363672	Filing Dt:	08/01/2023
Publication #:	US20240010702	Pub Dt:	01/11/2024
Title:	T CELL RECEPTORS

Patent #:	NONE	Issue Dt:		Application #:	18546821	Filing Dt:	08/17/2023
Publication #:	US20240124841	Pub Dt:	04/18/2024
Title:	METHODS OF PRODUCING HAEMOGENIC ENDOTHELIAL CELLS FROM PLURIPOTENT STEM CELLS

Patent #:	NONE	Issue Dt:		Application #:	18600309	Filing Dt:	03/08/2024
Publication #:	US20240301026	Pub Dt:	09/12/2024
Title:	COMPOSITIONS AND METHODS FOR TCR REPROGRAMMING USING FUSION PROTEINS

Assignors

TCR2 THERAPEUTICS INC.

Exec Dt:

05/14/2024

ADAPTIMMUNE LIMITED

Exec Dt:

05/14/2024

Assignee

HERCULES CAPITAL, INC., AS AGENT

400 HAMILTON AVENUE

SUITE 310

PALO ALTO, CALIFORNIA 94301

Correspondence name and address
	KHADIJAH SAMPSON
	1025 CONNECTICUT AVE NW, SUITE 712
	COGENCY GLOBAL INC.
	WASHINGTON, DC 20036

Search Results as of: 09/23/2024 05:21 PM

If you have any comments or questions concerning the data displayed, contact PRD / Assignments at 571-272-3350. v.2.6

Web interface last modified: August 25, 2017 v.2.6